InvestorsHub Logo
Followers 18
Posts 1416
Boards Moderated 0
Alias Born 12/03/2013

Re: dr_lowenstein post# 31898

Wednesday, 07/29/2015 6:31:48 PM

Wednesday, July 29, 2015 6:31:48 PM

Post# of 48316
Patients should be enrolled very soon. They are trying to turn non-responders into responders, As far as I know, especially with Melanoma, they are the only company really addressing that. Dr. Pierce is an expert with respect to PD-l/anti-PDL-1. I have confidence that Dr. Pierce has confidence that ONCS will be able to do this. If that does happen, everything else will fall into place. Evaluations will take place 3 months after dosing starts. I suspect we will know soon after that whether it is or is not working. THAT is what is important. JMHO